Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial) (GENODON) NCT02625519

What is studied: It is the first clinical trial with a prospective and randomized design to assess the differences stimulation outcomes based on the gonadotropin used in patients with different genetic profiles.

Aim: We want to know the differences in the response to medication according to each woman’s genetic profile and the type of medication used.

Current status: Recruitment phase

Location: Instituto Bernabeu Alicante

For study details you can find them through the link